{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:37:57Z","timestamp":1767065877093,"version":"3.40.3"},"publisher-location":"Cham","reference-count":14,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030117221"},{"type":"electronic","value":"9783030117238"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-11723-8_4","type":"book-chapter","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T13:47:41Z","timestamp":1548424061000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Update on Machine Learning in Neuro-Oncology Diagnostics"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-3998","authenticated-orcid":false,"given":"Thomas C.","family":"Booth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"key":"4_CR1","unstructured":"FDA-NIH Biomarker Working Group: BEST (Biomarkers, EndpointS, and other Tools) Resource. Food and Drug Administration (US), Silver Spring. Co-published by National Institutes of Health (US), Bethesda (2016)"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"D MacDonald","year":"2010","unstructured":"MacDonald, D., Cascino, T.L., Schold, S.C., Cairncross, J.G.: Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 8, 1277\u20131280 (2010). https:\/\/doi.org\/10.1200\/JCO.1990.8.7.1277","journal-title":"J. Clin. Oncol."},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen, P.Y., Macdonald, D.R., Reardon, D.A., Cloughesy, T.F., Sorensen, A.G., Galanis, E.: Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963\u20131972 (2010). https:\/\/doi.org\/10.1200\/JCO.2009.26.3541","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"4_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3174\/ajnr.A2061","volume":"31","author":"A Kassner","year":"2010","unstructured":"Kassner, A., Thornhill, R.E.: Texture analysis: a review of neurologic MR imaging applications. Am. J. Neuroradiol. 31(5), 809\u2013816 (2010). https:\/\/doi.org\/10.3174\/ajnr.A2061","journal-title":"Am. J. Neuroradiol."},{"issue":"9","key":"4_CR5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","volume":"20","author":"DN Cagney","year":"2017","unstructured":"Cagney, D.N., Sul, J., Huang, R.Y., Ligon, K.L., Wen, P.Y., Alexander, B.M.: The FDA NIH biomarkers, endpoints, and other tools (BEST) resource in neuro-oncology. Neuro. Oncol. 20(9), 1162\u20131172 (2017). https:\/\/doi.org\/10.1093\/neuonc\/nox242","journal-title":"Neuro. Oncol."},{"key":"4_CR6","unstructured":"Howick, J., et al.: OCEBM Table of Evidence Working Group: The Oxford 2011 Levels of Evidence (2011). http:\/\/www.cebm.net\/index.aspx?o=5653. Oxford Centre for Evidence-Based Medicine, Oxford (2016)"},{"issue":"6","key":"4_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D.N., et al.: The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131(6), 803\u2013820 (2016). https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol."},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/neuonc\/now121","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang, B., et al.: Multimodel MRI features predict isocitrate dehydrogenase genotype in high grade gliomas. Neuro. Oncol. 19, 109\u2013117 (2017)","journal-title":"Neuro. Oncol."},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/now256","volume":"19","author":"H Zhou","year":"2017","unstructured":"Zhou, H., et al.: MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro. Oncol. 19, 862\u2013870 (2017)","journal-title":"Neuro. Oncol."},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"30344","DOI":"10.1038\/srep30344","volume":"6","author":"R Inano","year":"2016","unstructured":"Inano, R., et al.: Visualization of heterogeneity and regional grading of gliomas by multiple features using magneteic resonance-based clustered images. Sci. Rep. 6, 30344 (2016)","journal-title":"Sci. Rep."},{"issue":"5","key":"4_CR11","doi-asserted-by":"publisher","first-page":"e0176528","DOI":"10.1371\/journal.pone.0176528","volume":"12","author":"TC Booth","year":"2017","unstructured":"Booth, T.C., et al.: Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma. PLoS One 12(5), e0176528 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0176528","journal-title":"PLoS One"},{"issue":"5","key":"4_CR12","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.18632\/oncotarget.14166","volume":"8","author":"S Kebir","year":"2016","unstructured":"Kebir, S., et al.: Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high grade glioma. Oncotarget 8(5), 8294\u20138304 (2016)","journal-title":"Oncotarget"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/neuonc\/nov127","volume":"18","author":"L Macyszyn","year":"2016","unstructured":"Macyszyn, L., et al.: Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro. Oncol. 18, 417\u2013425 (2016)","journal-title":"Neuro. Oncol."},{"key":"4_CR14","doi-asserted-by":"publisher","unstructured":"Chato, L., Latifi, S.: Machine learning and deep learning techniques to predict overall survival of brain tumor patients using MRI images. In: 17th IEEE International Conference on Bioinformatics and Engineering. IEEE Press, New York (2017). https:\/\/doi.org\/10.1109\/bibe.2017.00009","DOI":"10.1109\/bibe.2017.00009"}],"container-title":["Lecture Notes in Computer Science","Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-11723-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:57:17Z","timestamp":1710345437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-11723-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030117221","9783030117238"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-11723-8_4","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"26 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"BrainLes","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International MICCAI Brainlesion Workshop","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Granada","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Spain","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2018","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 September 2018","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 September 2018","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"4","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iwb2018","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/www.brainlesion-workshop.org\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Microsoft CMT","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"95","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"92","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"0","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"97% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}